COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,248 Articles (22,733 medRxiv, 8,515 bioRxiv)

Most recent first Previous |  Page 2236: Articles 22351-22360  | Next

IMPACT OF UNIVERSITY RE-OPENING ON TOTAL COMMUNITY COVID-19 BURDEN
Cipriano, L. E., Haddara, W. M. R., Zaric, G. S., Enns, E. A.
10.1101/2020.09.18.20197467 — Posted: 2020-09-18
Metabolic stress and disease-stage specific basigin expression of peripheral blood immune cell subsets in COVID-19 patients
Siska, P. J., Singer, K., Klitzke, J., Kauer, N., Decking, S.-M., Bruss, C., Matos, C., Kolodova, K., Peuker, A., Schoenhammer, G., Raithel, J., Lunz, D., Graf, B., Geismann, F., Lubnow, M., Mack, M., Hau, P., Bohr, C., Burkhardt, R., Gessner, A., Salzberger, B., Hanses, F., Hitzenbichler, F., Heudobler, D., Lueke, F., Pukrop, T., Herr, W., Wolff, D., Poeck, H., Brochhausen, C., Hoffmann, P., Rehli, M., Kreutz, M., Renner, K.
10.1101/2020.09.18.20194175 — Posted: 2020-09-18
The epidemiological characteristics of COVID-19 in Libya during the ongoing-armed conflict.
Daw, M. A., El-Bouzedi, A. H., Ahmed, M. O., Alejenef, A. A.
10.1101/2020.09.17.20196352 — Posted: 2020-09-18
CLINICALLY DISTINCT COVID-19 CASES SHARE STRIKINGLY SIMILAR IMMUNE RESPONSE PROGRESSION: A FOLLOW-UP ANALYSIS
Hausburg, M., Banton, K. L., Roshon, M., Bar-Or, D.
10.1101/2020.09.16.20115972 — Posted: 2020-09-18
How the clinical research community responded to the COVID-19 pandemic: An analysis of the COVID-19 clinical studies in ClinicalTrials.gov
He, Z., Erdengasileng, F., Luo, X., Xing, A., Charness, N., Bian, J.
10.1101/2020.09.16.20195552 — Posted: 2020-09-18
Inflammatory leptomeningeal cytokines mediate delayed COVID-19 encephalopathy
Remsik, J., Wilcox, J. A., Babady, N. E., McMillen, T., Vachha, B. A., Halpern, N. A., Dhawan, V., Rosenblum, M., Iacobuzio-Donahue, C. A., Avila, E. K., Santomasso, B., Boire, A.
10.1101/2020.09.15.20195511 — Posted: 2020-09-18
A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent in vitro
Xiao, T., Lu, J., Zhang, J., Johnson, R. I., McKay, L. G. A., Storm, N., Lavine, C. L., Peng, H., Cai, Y., Rits-Volloch, S., Lu, S., Quinlan, B. D., Farzan, M., Seaman, M. S., Griffiths, A., Chen, B.
10.1101/2020.09.18.301952 — Posted: 2020-09-18
Discovery of SARS-CoV-2 antiviral synergy between remdesivir and approved drugs in human lung cells
Nguyenla, X., Wehri, E., Van Dis, E., Biering, S., Yamashiro, L. H., Stroumza, J., Dugast-Darzacq, C., Graham, T., Stanley, S., Schaletzky, J.
10.1101/2020.09.18.302398 — Posted: 2020-09-18
The COVID-19 immune landscape is dynamically and reversibly correlated with disease severity
Bolouri, H., Speake, C., Skibinski, D., Long, S. A., Hocking, A. M., Campbell, D. J., Hamerman, J. A., Malhotra, U., Buckner, J. H., BRI COVID-19 Research Team
10.1101/2020.09.18.303420 — Posted: 2020-09-18
The Peak of COVID-19 in India
Yadav, S., YADAV, P. K.
10.1101/2020.09.17.20197087 — Posted: 2020-09-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).